Market Closed -
Nasdaq Helsinki
11:29:55 2024-05-03 am EDT
5-day change
1st Jan Change
4.945
EUR
+6.80%
+23.93%
+33.11%
Sales 2024 *
16.79M
18.02M
Sales 2025 *
25.35M
27.2M
Capitalization
82.3M
88.31M
Net income 2024 *
-3M
-3.22M
Net income 2025 *
-2M
-2.15M
EV / Sales 2024 *
4.96
x
Net Debt
2024
*
965K
1.04M
Net Debt
2025
*
4.58M
4.91M
EV / Sales 2025 *
3.43
x P/E ratio 2024 *
-21
x
P/E ratio 2025 *
-29.9
x
Employees
114
Yield 2024 *
-
Yield 2025 *
-
Free-Float
87.37%
Duration
1 day 1 week 1 month 3 months 6 months 1 year 5 years 10 years
Period
5 minutes 15 minutes 30 minutes 1 hour 1 day 1 week 1 month 1 year
Style
CandleStick End-of-day OHLC Mountain
Dynamic Chart
Optomed USA, Inc. Introduces Optomed Aurora AEYE
May. 01
CI
Optomed Oyj, AEYE Health say portable device to detect eye issues gets FDA nod
May. 01
RE
Optomed Plc Announces Optomed Aurora with AEYE Receives U.S. Food & Drug Administration Clearance in US
Apr. 30
CI
Optomed Plc Provides Revenue Guidance for the Full Year of 2024
Apr. 30
CI
Transcript : Optomed Oyj, 2023 Earnings Call, Feb 15, 2024
Feb. 15
Optomed Oyj Reports Earnings Results for the Full Year Ended December 31, 2023
Feb. 15
CI
Optomed Oyj Provides Revenue Guidance for the Full Year 2024
Feb. 15
CI
Optomed Oyj Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Feb. 15
CI
Optomed Oyj Announces Nomination Board
Jan. 10
CI
Transcript : Optomed Oyj, Nine Months 2023 Earnings Call, Nov 03, 2023
Nov. 03
Optomed Oyj Provides Revenue Guidance for the Year 2023
Nov. 03
CI
Optomed Oyj Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nov. 03
CI
Optomed to Raise EUR4 Million Via Share Issue
23-09-21
MT
Optomed plc Announces Composition of Its Nomination Board
23-09-12
CI
Optomed to Supply Large Diabetic Retinopathy Screening Solution to Spain
23-08-18
CI
More news
AVIS D'ANALYSTES DU JOUR : Stellantis, Schneider, Renault, Safran, Airbus, Valeo,Gecina, FDJ...
Feb. 16
Wall Street plane, le luxe atterrit en catastrophe
23-09-26
AVIS D'ANALYSTES DU JOUR : Kering, Axa, Eurofins, Hermès, Scor, Nexi, Fnac, Aperam, ArgenX...
23-09-26
Small Caps : les derniers choix des stars de la gestion
22-02-17
More news 1 week +10.63%
Current month +17.22%
1 month +14.60%
3 months +20.10%
6 months +85.94%
Current year +24.63%
More quotes
Managers
Title Age Since
Chief Executive Officer
54
23-09-30
Director of Finance/CFO
40
18-12-31
Chief Tech/Sci/R&D Officer
-
-
Members of the board
Title Age Since
Chairman
66
05-12-31
Director/Board Member
72
18-12-31
Director/Board Member
68
18-12-31
More insiders
Date
Price
Change
Volume
24-05-03
4.945
+6.80%
424 535
24-05-02
4.63
-7.40%
251,454
24-04-30
5
+13.64%
425,073
24-04-29
4.4
+7.06%
232,628
24-04-26
4.11
+3.01%
26,049
Delayed Quote
Nasdaq Helsinki, May 03, 2024 at 03:11 am EDT
More quotes
Optomed Oyj is a Finland-based medical technology company and a producer of handheld fundus cameras globally. The Group's Parent Company, Optomed Oyj, is responsible for, among other things, the management of the Group as well as finance and accounting functions, human resources, legal affairs and corporate communication. The Group's business is managed through two reportable segments: Devices and Software. The Devices segment develops, commercializes and manufactures easy-to-use and affordable handheld fundus cameras. The Software segment develops and sells screening software for diabetic retinopathy and cancer screening for healthcare organizations. The Optomed Group consists of the parent company Optomed Oyj and four subsidiaries in Finland, China, the USA and Hong Kong.
More about the company
Last Close Price
4.63
EUR
Average target price
6.2
EUR
Spread / Average Target
+33.91%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1